Manher Joshi - 16 Nov 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Nov 2023, 17:30:19 UTC
Prior SEC filing
18 Aug 2023
Next SEC filing
12 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Manher Joshi

Key filing fact

Manher Joshi filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 20 Nov 2023.

Key facts

  • This page summarizes Manher Joshi's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Nov 2023, 17:30.

Change

  • Previous filing in this sequence was filed on 18 Aug 2023.
  • Current net transaction value: -$4,780.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRA transaction

Common Stock

Sale

Transaction value
$4,780
Shares
-12,287
Change %
-6.7%
Price
$0.3890
Shares after
171,284
Date
16 Nov 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.

Footnote F2

The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .